Michael B. Harlin
Advertisement
Partner at Neal Gerber Eisenberg, specializing in life sciences intellectual property.
Articles by Michael B. Harlin
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Roundup: Novartis & Abogen Enter Licensing and Option Agreement, AstraZeneca and Daiichi Sankyo Enter Clinical Collaboration with Summit Therapeutics
2
Foghorn Therapeutics & Eli Lilly Halt Fhd-909 Development Following Phase I Data
3
How a Shift Towards Oral Medications Impacts GLP-1s
4
The Next Chapter in Metabolic Drug Development
5